spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  technetium 

 HSMN NewsFeed - 10 Jun 2021
Cardinal Health(TM) Nuclear & Precision Health Solutions Receives U.S. Food and Drug Administration Approval for New LYMPHOSEEK(R) Pediatric Indication
Biopharmaceuticals Radiology Oncology FDA
 HSMN NewsFeed - 15 Oct 2014
Navidea Announces Rick Gonzalez as New Chief Executive Officer
Biopharmaceuticals Diagnostics Personnel
 HSMN NewsFeed - 26 Sep 2014
Navidea’s Lymphoseek(R) Recommended by CHMP for European Approval in Sentinel Lymph Node Detection for Melanoma, Breast and Certain Head and Neck Cancers
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 11 Jun 2014
Navidea Biopharmaceuticals’ Lymphoseek(R) (technetium Tc 99m tilmanocept) Injection Demonstrates Preferential Accumulation in Tumor-Positive Sentinel Lymph Nodes in Post-Hoc Analysis
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 May 2014
Mallinckrodt Pharmaceuticals’ New Drug Application Accepted for Review by FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Apr 2014
Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Enter Into Definitive Merger Agreement Under Which Mallinckrodt Will Acquire Questcor For Approximately $5.6 Billion, Creating A Diversified, High-Growth Specialty Pharmaceuticals Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Mar 2014
Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Feb 2014
Mallinckrodt plc to Acquire Cadence Pharmaceuticals, Inc. for $14.00 Per Share, in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Jan 2014
Mallinckrodt Pharmaceuticals and Medtronic Announce Clinical and Commercial Collaboration
Biopharmaceuticals Devices Drug Delivery Neurology
 HSMN NewsFeed - 9 Jan 2014
Mallinckrodt Pharmaceuticals and Zogenix to End Co-Promotion Agreement
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 7 Jan 2014
Navidea Biopharmaceuticals Expands Lymphoseek(R) Global Commercialization Efforts
Biopharmaceuticals Radiology Distribution
 HSMN NewsFeed - 10 Dec 2013
FDA Grants Fast Track Designation to Navidea Biopharmaceuticals’ Lymphoseek(R) for Sentinel Lymph Node Detection in Patients with Head and Neck Cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 25 Nov 2013
U.S. Food and Drug Administration (FDA) Extends Review of Mallinckrodt’s New Drug Application for XARTEMIS(TM) XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets (CII)
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Aug 2013
Mallinckrodt Pharmaceuticals Signs Distribution Agreement with Amneal Pharmaceuticals LLC
Biopharmaceuticals Generics Distribution
 HSMN NewsFeed - 11 Jul 2013
Lantheus Medical Imaging Announces Chief Financial Officer Transition
Biopharmaceuticals Radiology Personnel
 HSMN NewsFeed - 15 Apr 2013
Lantheus Medical Imaging Realigns Executive Leadership Team
Biopharmaceuticals Radiology Personnel
 HSMN NewsFeed - 21 Mar 2013
Results of Lymphoseek(R) Phase 3 Clinical Trials in Breast Cancer Published in Annals of Surgical Oncology
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Jan 2013
Mallinckrodt Announces Approval of New Gablofen(R) Prefilled Syringe
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 2 Oct 2012
Mallinckrodt Completes Acquisition of CNS Therapeutics, Inc.
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 18 Jul 2012
Lantheus Medical Imaging Announces Appointment of Michael W. Heslop as Vice President, International
Diagnostics Devices Radiology Personnel
 HSMN NewsFeed - 27 Jul 2011
Lantheus Medical Imaging Announces Management Change
Devices Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Mar 2011
Lantheus Medical Imaging Receives Special Protocol Assessment Approval from FDA for Phase 3 Trial of Flurpiridaz F-18 for the Diagnosis of Coronary Artery Disease
Biopharmaceuticals Radiology Cardiology FDA
 HSMN NewsFeed - 10 Mar 2011
Covidien Receives FDA Approval for South African-Produced Medical Isotope Based on Low-Enriched Uranium
Devices Radiology FDA
 HSMN NewsFeed - 21 Jan 2011
Lantheus Medical Imaging Announces New National Contract with Novation for ABLAVAR(R) and DEFINITY(R)
Biopharmaceuticals Radiology Distribution
 HSMN NewsFeed - 17 Feb 2010
Lantheus Medical Imaging, Inc. Announces Appointment of Robert A. Spurr as Vice President, Sales and Marketing
Biopharmaceuticals Radiology Personnel
 HSMN NewsFeed - 17 Feb 2010
Covidien Announces New Source of Vital Medical Isotopes
Diagnostics Radiology
 HSMN NewsFeed - 20 Jan 2010
Lantheus Medical Imaging, Inc. Launches ABLAVAR (Gadofosveset Trisodium), a New Diagnostic Magnetic Resonance Angiography Agent
Biopharmaceuticals Radiology
 HSMN NewsFeed - 6 Jul 2009
Covidien Announces Health Canada Approval for its Generic Myocardial Perfusion Imaging Kit
Biopharmaceuticals Generics Radiology Regulatory
 HSMN NewsFeed - 12 Jun 2009
BARI 2D Study Presented at American Diabetes Association Scientific Sessions Underscores Utility of SPECT Myocardial Perfusion Imaging in Identifying Cardiovascular Risk and Evaluating Treatment Outcomes for Patients with Type 2 Diabetes
Biopharmaceuticals Radiology Cardiology
 HSMN NewsFeed - 7 Apr 2009
EPIX Pharmaceuticals Announces Sale of U.S., Canadian and Australian Rights for MS-325 (formerly marketed as Vasovist, gadofosveset trisodium, by Bayer Schering Pharma) to Lantheus Medical Imaging, Inc.
Biopharmaceuticals Radiology Acquisitions
 HSMN NewsFeed - 23 Sep 2008
Bracco Diagnostics Inc. and Lantheus Medical Imaging Enter into Agreement to Co-Promote Bracco's CardioGen-82(R) (Rubidium Rb 82 Generator)
Biopharmaceuticals Radiology
 HSMN NewsFeed - 23 Sep 2008
Covidien Announces FDA Approval for its Generic Myocardial Perfusion Imaging Kit
Biopharmaceuticals Generics Radiology FDA
 HSMN NewsFeed - 18 Mar 2008
Cardinal Health, GE Healthcare Broaden Relationship to Offer Greater Access to Myoview(TM) Imaging Agent
Biopharmaceuticals Radiology
 HSMN NewsFeed - 18 Mar 2008
Worldwide Leader in Diagnostic Medicine is Launched as Lantheus Medical Imaging
Biopharmaceuticals Radiology
 HSMN NewsFeed - 27 Feb 2008
Covidien Announces Tentative FDA Approval for Its Generic Myocardial Perfusion Imaging Kit
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Dec 2007
GE Healthcare Announces Expansion of Nuclear Cardiology Portfolio for Medical Diagnostics Business
Biopharmaceuticals Radiology Distribution
 HSMN NewsFeed - 20 Dec 2007
DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
Biopharmaceuticals Radiology Distribution
 HSMN NewsFeed - 3 Dec 2007
Neoprobe's Lymphoseek Issued Japanese Patent
Diagnostics
 HSMN NewsFeed - 27 Nov 2007
Neoprobe and Cardinal Health Sign Distribution Agreement for Lymphoseek
Biopharmaceuticals Diagnostics Distribution
 HSMN NewsFeed - 12 Jul 2007
Neoprobe and Cardinal Health Sign Term Sheet for Lymphoseek Distribution
Diagnostics Oncology Distribution
 HSMN NewsFeed - 27 Jun 2007
Alseres Pharmaceuticals Announces FDA Clearance to Increase Dose Level in Cethrin(R) Phase I/IIa Clinical Trial for Acute Spinal Cord Injury at U.S. Sites
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 20 Jun 2007
Neoprobe Phase 2 Lymphoseek Trial Meets Primary Endpoint
Devices Oncology
 HSMN NewsFeed - 8 Jun 2007
Boston Life Sciences, Inc. Changes Name to Alseres Pharmaceuticals, Inc.
Biopharmaceuticals
 HSMN NewsFeed - 29 May 2007
Boston Life Sciences Names Scientific and Clinical Advisors for Nerve Repair Program
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2007
Boston Life Sciences, Inc. Announces Presentation of Cethrin(R) Phase I/IIa 6-Month Results at 75th Annual Meeting of the American Association of Neurological Surgeons
Biopharmaceuticals Neurology
 HSMN NewsFeed - 16 Apr 2007
Boston Life Sciences Appoints Frank Bobe as Executive Vice President and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Mar 2007
Dr. Robert Langer Named as Chairman of Boston Life Sciences, Inc. Newly Formed Science and Technology Committee of the Board of Directors
Devices Personnel
 HSMN NewsFeed - 13 Mar 2007
Mallinckrodt Initiates Voluntary Imaging Product Recall
Devices Radiology Product Recall
 HSMN NewsFeed - 2 Feb 2007
DRAXIS Radiopharmaceuticals Division Applies to FDA to Market Cardiac Imaging Product
Biopharmaceuticals Generics Radiology
 HSMN NewsFeed - 4 Jan 2007
Boston Life Sciences Acquires Rights to Develop and Commercialize Promising Phase II Spinal Cord Injury Drug, Cethrin(R), in Exclusive Worldwide License
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 25 Sep 2006
Boston Life Sciences, Inc. Announces Findings from Review of POET-1 Study of ALTROPANE(R) Molecular Imaging Agent
Biopharmaceuticals Radiology Neurology
 HSMN NewsFeed - 12 Sep 2006
CellPoint Adds Former Chief Medical Officer of Philips Medical Systems, F. David Rollo, M.D., Ph.D., as President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2006
Xanthus Pharmaceuticals Appoints John Lister-James, Ph.D. as Vice President, Development
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 28

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 28 additional stories matching:
technetium
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.